betamethasone-17,21-dipropionate has been researched along with Dermatosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glick, BP; Touloei, K; Wiener, A | 1 |
| Dytoc, MT; Kossintseva, I; Ting, PT | 1 |
| Eubanks, LE; Galen, W; McBurney, EI; Reed, R | 1 |
2 review(s) available for betamethasone-17,21-dipropionate and Dermatosclerosis
| Article | Year |
|---|---|
Solitary morphea profunda following trauma sustained in an automobile accident.
Topics: Accidents, Traffic; Anti-Inflammatory Agents; Antirheumatic Agents; Arm Injuries; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Middle Aged; Prednisone; Scleroderma, Localized | 2015 |
Linear scleroderma in children.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betamethasone; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Penicillins; Phenytoin; Scleroderma, Localized; Ticlopidine; Vitamin E | 1996 |
1 other study(ies) available for betamethasone-17,21-dipropionate and Dermatosclerosis
| Article | Year |
|---|---|
First case series on the use of calcipotriol-betamethasone dipropionate for morphoea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Humans; Male; Middle Aged; Scleroderma, Localized; Treatment Outcome | 2007 |